Book contents
- Frontmatter
- Dedication
- Contents
- List of Contributors
- Preface
- Section 1 Historical perspective
- Section 2 Life cycle
- Section 3 Developmental biology
- Section 4 Imprinting and reprogramming
- Section 5 Pathology
- 24 Gene expression in human oocytes
- 25 Omics as tools for oocyte selection
- 26 The legacy of mitochondrial DNA
- 27 Relative contribution of advanced age and reduced follicle pool size on reproductive success
- 28 Cellular origin of age-related aneuploidy in mammalian oocytes
- 29 Alterations in the gene expression of aneuploid oocytes and associated cumulus cells
- 30 Transgenerational risks by exposure in utero
- 31 Obesity and oocyte quality
- 32 Safety of ovarian stimulation
- 33 Oocyte epigenetics and the risks for imprinting disorders associated with assisted reproduction
- 34 Genetic basis for primary ovarian insufficiency
- Section 6 Technology and clinical medicine
- Index
- References
24 - Gene expression in human oocytes
from Section 5 - Pathology
Published online by Cambridge University Press: 05 October 2013
- Frontmatter
- Dedication
- Contents
- List of Contributors
- Preface
- Section 1 Historical perspective
- Section 2 Life cycle
- Section 3 Developmental biology
- Section 4 Imprinting and reprogramming
- Section 5 Pathology
- 24 Gene expression in human oocytes
- 25 Omics as tools for oocyte selection
- 26 The legacy of mitochondrial DNA
- 27 Relative contribution of advanced age and reduced follicle pool size on reproductive success
- 28 Cellular origin of age-related aneuploidy in mammalian oocytes
- 29 Alterations in the gene expression of aneuploid oocytes and associated cumulus cells
- 30 Transgenerational risks by exposure in utero
- 31 Obesity and oocyte quality
- 32 Safety of ovarian stimulation
- 33 Oocyte epigenetics and the risks for imprinting disorders associated with assisted reproduction
- 34 Genetic basis for primary ovarian insufficiency
- Section 6 Technology and clinical medicine
- Index
- References
Summary
Introduction
Early embryonic development of the human oocyte, as for the oocytes of all mammalian species, is under the control of the maternally inherited genome. It is not until the 4- to 8-cell stage of development in the human that the maternal genome is fully replaced by a transcriptionally active embryonic genome [1]. The maternal transcripts that control the events of mammalian oocyte growth, meiotic maturation, fertilization, and early embryonic development are transcribed and accumulated during oogenesis.
Transcription in primary human oocytes begins at a relatively high level during fetal life with levels falling in leptotene and zygotene and falling further, to almost undetectable levels, by early pachytene [2]. Transcription levels then rise again through mid-pachytene returning to levels similar to those observed in oogonia by the early diplotene stage [2]. Studies in the mouse suggest that transcription levels remain active, but low, in the mammalian oocytes in the resting pool within the ovary but increase significantly and dramatically when the oocyte enters the growth phase, peaking at the time that maximal oocyte diameter is attained and then falling from this point to very low levels a few hours before ovulation (Figure 24.1) [3–5]. During the growth phase there is no significant difference in the rates of accumulation of rRNA, tRNA, polyadenylated RNA, or specific mRNAs [6–8].
- Type
- Chapter
- Information
- Biology and Pathology of the OocyteRole in Fertility, Medicine and Nuclear Reprograming, pp. 285 - 296Publisher: Cambridge University PressPrint publication year: 2013
References
- 1
- Cited by